Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Fish and Richardson
US Department of Justice
Queensland Health

Generated: December 10, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 070299

« Back to Dashboard

NDA 070299 describes NALOXONE, which is a drug marketed by West-ward Pharms Int, Wyeth Ayerst, Abraxis Pharm, Akorn, Astrazeneca, Eurohlth Intl Sarl, Hospira, Igi Labs Inc, Intl Medication, Marsam Pharms Llc, Mylan Institutional, Smith And Nephew, Solopak, Somerset Theraps Llc, Watson Labs, Gavis Pharms, and Sun Pharm Inds Ltd, and is included in fifty-six NDAs. It is available from one supplier. Additional details are available on the NALOXONE profile page.

The generic ingredient in NALOXONE is naloxone hydrochloride; pentazocine hydrochloride. There are twelve drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the naloxone hydrochloride; pentazocine hydrochloride profile page.
Summary for 070299
Applicant:West-ward Pharms Int
Ingredient:naloxone hydrochloride
Formulation / Manufacturing:see details
Pharmacology for NDA: 070299
Mechanism of ActionOpioid Antagonists
Medical Subject Heading (MeSH) Categories for 070299
Suppliers and Packaging for NDA: 070299
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NALOXONE naloxone hydrochloride INJECTABLE;INJECTION 070299 ANDA West-Ward Pharmaceuticals Corp. 0641-6132 0641-6132-25 25 VIAL in 1 CARTON (0641-6132-25) > 1 mL in 1 VIAL (0641-6132-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength0.4MG/ML
Approval Date:Sep 24, 1986TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
US Department of Justice
Boehringer Ingelheim
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.